Literature DB >> 7835227

Formation of toxic metabolites from thiabendazole and other thiazoles in mice. Identification of thioamides as ring cleavage products.

T Mizutani1, K Yoshida, S Kawazoe.   

Abstract

The metabolism of three nephro- or hepatotoxic thiazoles--2-(thiazol-4-yl)benzimidazole (thiabendazole) (1a), 4-tert-butyl-2-methyl-thiazole (1b), and 2-(p-methoxyphenyl)-4-methylthiazole (1c)--was examined in mice with special regard to the formation of ring cleavage products. By GC/MS analyses of derivatized metabolites and comparison with authentic samples, thioformamide and benzimidazol-2-ylglyoxal as the accompanying fragment were identified as urinary metabolites in mice dosed with 1a. Similarly, 1b produced thioacetamide and tert-butylglyoxal, and 1c produced p-methoxy-thiobenzamide (and its S-oxide) and methylglyoxal. These results could be explained by the postulated metabolic pathways where thiazoles would undergo microsomal epoxidation of the C = C double bond and, after being hydrolyzed, the resulting epoxide would then be decomposed to form the corresponding thioamides and alpha-dicarbonyl fragments.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7835227

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  5 in total

Review 1.  Enhancing insulin action: from chemical elements to thiazolidinediones.

Authors:  R Perfetti; K Chamie
Journal:  J Endocrinol Invest       Date:  2001-04       Impact factor: 4.256

2.  Metabolism of 4-[1-(2-fluoro-4-biphenylyl)ethyl]-2-methylaminothiazole (SM-8849) in rats.

Authors:  M Yabuki; J Shimakura; M Ito; H Kanamaru; K Iba; I Nakatsuka
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1997 Jan-Mar       Impact factor: 2.441

3.  Discovery of Potent N-Ethylurea Pyrazole Derivatives as Dual Inhibitors of Trypanosoma brucei and Trypanosoma cruzi.

Authors:  Swapna Varghese; Raphaël Rahmani; Stephanie Russell; Girdhar Singh Deora; Lori Ferrins; Arthur Toynton; Amy Jones; Melissa Sykes; Albane Kessler; Amanda Eufrásio; Artur Torres Cordeiro; Julian Sherman; Ana Rodriguez; Vicky M Avery; Matthew J Piggott; Jonathan B Baell
Journal:  ACS Med Chem Lett       Date:  2019-09-09       Impact factor: 4.345

4.  Meloxicam methyl group determines enzyme specificity for thiazole bioactivation compared to sudoxicam.

Authors:  Dustyn A Barnette; Mary A Schleiff; Arghya Datta; Noah Flynn; S Joshua Swamidass; Grover P Miller
Journal:  Toxicol Lett       Date:  2020-11-27       Impact factor: 4.372

5.  Dual mechanisms suppress meloxicam bioactivation relative to sudoxicam.

Authors:  Dustyn A Barnette; Mary A Schleiff; Laura R Osborn; Noah Flynn; Matthew Matlock; S Joshua Swamidass; Grover P Miller
Journal:  Toxicology       Date:  2020-05-11       Impact factor: 4.221

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.